| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
LYRA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.10M | $3.69M | - | |
| CFO | 518.5K | $1.74M | - | |
| 10% | 124.9K | $487.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2026 | Cavalier Jason | Chief Financial Officer | Sell | 769 | $3.36 | $2,586.92 | -0.1% | -85.4% | - | |
| Jan 6, 2026 | Palasis Maria85 | President &CEO | Sell | 1,702 | $3.36 | $5,725.53 | -0.2% | -85.4% | - | |
| Nov 13, 2025 | Perceptive Advisors LLC51 | 10% Owner | Sell | 45,875 | $3.98 | $182,515.31 | -76.6% | -64.1% | - | |
| Nov 10, 2025 | Perceptive Advisors LLC51 | 10% Owner | Sell | 70,390 | $4.89 | $344,219.10 | -79.0% | -65.5% | - | |
| Jul 10, 2025 | Palasis Maria85 | President &CEO | Sell | 1,565 | $8.91 | $13,944.15 | -0.1% | -14.8% | -94.0% | |
| Jul 10, 2025 | Cavalier Jason | Chief Financial Officer | Sell | 684 | $8.91 | $6,094.44 | -0.1% | -14.8% | -94.0% | |
| Nov 10, 2023 | Waksal Harlan | Executive Chair | Buy | 25,000 | $2.96 | $74,095.00 | +10.6% | +60.3% | -91.1% | |
| May 31, 2023 | Nbvm Gp, LLC | 10% Owner | Buy | 1,805,416 | $2.43 | $4,387,160.88 | +252.0% | +32.7% | -87.1% | |
| May 31, 2023 | Perceptive Advisors LLC51 | Director, 10% Owner | Buy | 3,610,832 | $2.49 | $8,999,998.76 | +45.9% | +32.7% | -87.1% | |
| May 31, 2023 | Anderson Edward T | Director, 10% Owner | Buy | 1,805,416 | $2.43 | $4,387,160.88 | +252.0% | +32.7% | -87.1% |